Light Up Your Life


Taiwan Biophotonic Co.,
funded by a team spin off from ITRI on April 22, 2014, targets itself as the global leading biophotonic company with full operations in research and development, manufacturing, marketing and sales of medical and healthcare related products and services. Core technologies of tBPC include noninvasive glucose meter and wearable vital sign monitoring devices.

 

Company Name: Taiwan Biophotonic Corporation (tBPC)
Founded Date: April 22, 2014
Chairman: Jackson Yu
President: JC Chen, Ph.D.

 
Target Markets
Diabetes:
The global blood glucose monitoring market was estimated as $8.9 billion in 2010. It is expected to reach $12.2 billion in 2017 (Source: ASDR).

Wearable Healthcare & IoT:
The global wearable devices market has been forecast as $1 billion in 2011, and will jump to $6 billion by 2016, at CAGR of 42% (Source: IMS Research).
 

 
Core Products
Non-invasive Glucose Meter 
that determines blood glucose levels based on the IR absorption and polarization at the aqueous humor without drawing blood through finger pricks, which is a painless, no infection risk, fast and convenient test.

Wearable Pulse Oximetry Devices
that measures heart rate and blood oxygen level at various skin positions without using a fingertip probe.